Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun:7:57-61.
doi: 10.1016/j.jdin.2022.02.002. Epub 2022 Feb 10.

Association between alopecia areata and COVID-19: A systematic review

Affiliations
Review

Association between alopecia areata and COVID-19: A systematic review

Rachel E Christensen et al. JAAD Int. 2022 Jun.

Abstract

Background: COVID-19 may play a role in various immune-related dermatologic conditions. The relationship between COVID-19 and alopecia areata remains unclear.

Objective: To review the existing literature for clinical studies and reports investigating the association between new-onset alopecia areata or the exacerbation of preexisting alopecia areata following infection with SARS-CoV-2.

Methods: A systematic review of the literature was performed using PubMed, Embase, and MEDLINE databases from inception to October 2021. Included articles assessed alopecia areata following infection with SARS-CoV-2.

Results: Of 402 total articles, 9 were identified as meeting the inclusion criteria. Six articles described case reports of 7 patients with new-onset alopecia areata following confirmed infection with SARS-CoV-2, and 3 articles reported on alopecia areata recurrence or exacerbation following SARS-CoV-2 infection in patients with preexisting disease. Studies investigating the exacerbation or recurrence of alopecia areata following infection reported mixed findings.

Limitations: A majority of the included studies were case reports. The heterogeneity of articles precluded data synthesis.

Conclusion: Alopecia areata may be a dermatologic manifestation of COVID-19, with cases most often appearing 1 to 2 months following infection. Additional research is necessary to better elucidate the relationship and draw conclusions.

Keywords: AA; COVID-19; SARS-CoV-2; alopecia areata; inflammation.

PubMed Disclaimer

Conflict of interest statement

None disclosed.

Figures

Fig 1
Fig 1
Flow diagram of the systematic study selection process.

References

    1. Schwartzberg L.N., Advani S., Clancy D.C., Lin A., Jorizzo J.L. A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis. Skin Health Dis. 2021;1(2) doi: 10.1002/ski2.20. - DOI - PMC - PubMed
    1. Matar S., Oulès B., Sohier P., et al. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature. J Eur Acad Dermatol Venereol. 2020;34(11):e686–e689. doi: 10.1111/jdv.16775. - DOI - PMC - PubMed
    1. Lee H.H., Gwillim E., Patel K.R., et al. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;82(3):675–682. doi: 10.1016/j.jaad.2019.08.032. - DOI - PubMed
    1. Kutlu Ö, Aktaş H, İmren IG, Metin A. Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic. J Dermatolog Treat. Published online June 19, 2020. 10.1080/09546634.2020.1782820 - DOI - PubMed
    1. Zhou C., Li X., Wang C., Zhang J. Alopecia areata: an update on etiopathogenesis, diagnosis, and management. Clin Rev Allergy Immunol. 2021;61(3):403–423. doi: 10.1007/s12016-021-08883-0. - DOI - PubMed